Advertisement

Related Videos

Ian Tannock, MD, PhD, DSc, on Near-Equivalence: A Better Question Than Non-Inferiority

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, on Alternative Dispensing Strategies

Welcome and Introduction to Vi3C

Gary L. Rosner, ScD, on Bayesian Non-Inferiority

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

Advertisement

Advertisement




Jan
21
Today In Oncology
Regulatory Agencies Establish Principles of Good AI Use in Drug Development
Addition of Durvalumab to BCG After TURBT for BCG-Naive, High-Risk NMIBC
IMvigor011 Subgroup Analysis: Role of ctDNA in Guiding Adjuvant Treatment for Muscle-Invasive Bladder Cancer
KEYNOTE-905: Perioperative Immunotherapy Regimen Active in Cisplatin-Ineligible MIBC
Limited or No State Regulation of STLD Health Plans Linked to Decreases in Timely Cancer Treatment Initiation
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo